Oppenheimer Maintains Outperform on Prothena Corp, Lowers Price Target to $62
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Jay Olson maintains an Outperform rating on Prothena Corp (NASDAQ:PRTA) but lowers the price target from $66 to $62.
August 14, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oppenheimer analyst Jay Olson maintains an Outperform rating on Prothena Corp but lowers the price target from $66 to $62.
The Outperform rating suggests continued confidence in Prothena's performance, but the lowered price target indicates some tempered expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100